store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
A-802715 是一种新型甲基黄嘌呤衍生物,可降低促炎物质的内源性形成和血液水平,并增加白细胞介素10受体和肿瘤坏死因子受体等抗炎物质的形成和血液水平。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,290 | 现货 | ||
2 mg | ¥ 1,780 | 现货 | ||
5 mg | ¥ 2,650 | 现货 | ||
10 mg | ¥ 4,230 | 现货 | ||
25 mg | ¥ 6,580 | 现货 | ||
50 mg | ¥ 8,880 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,880 | 现货 |
产品描述 | A-802715 is a novel methylxanthine derivative that decreases the endogenous formation and blood levels of pro-inflammatory substances and increases the formation and blood levels of anti-inflammatory substances such as interleukin 10 receptor and tumor necrosis factor receptor. |
体外活性 | The toxicity of the methylxanthine derivative A802715 is determined against the two human melanoma lines, Be11 and MeWo, and against the two human squamous cell carcinoma lines, 4197 and 4451, by vital dye staining assay. A802715, with a TD50 of 0.9-1.1 mM, is the most toxic. BrdU incorporations in p53 wt cells show that A802715 strongly enhances the irradiation-induced suppression of S-phase entry. Depending on the p53 status of the cell line, A802715 either prolongs the G2/M block or remains ineffective[1]. |
分子量 | 322.4 |
分子式 | C16H26N4O3 |
CAS No. | 107767-58-8 |
store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (186.10 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.1017 mL | 15.5087 mL | 31.0174 mL | 77.5434 mL |
5 mM | 0.6203 mL | 3.1017 mL | 6.2035 mL | 15.5087 mL | |
10 mM | 0.3102 mL | 1.5509 mL | 3.1017 mL | 7.7543 mL | |
20 mM | 0.1551 mL | 0.7754 mL | 1.5509 mL | 3.8772 mL | |
50 mM | 0.062 mL | 0.3102 mL | 0.6203 mL | 1.5509 mL | |
100 mM | 0.031 mL | 0.1551 mL | 0.3102 mL | 0.7754 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
A-802715 107767-58-8 Immunology/Inflammation IL Receptor A 802715 A802715 Inhibitor inhibitor inhibit